Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DocGo Inc.DCGO · Entity 7359 | Director · General Counsel and Secretary | December 12, 2025 | December 16, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DocGo Inc.
Report date December 12, 2025 · Filed December 16, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 258,795 |
Last balance in matching sequence
After 2025-12-15 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2025-12-12 · Grant · Acquired 100,000 · Balance 275,645 F1: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). The RSUs will vest in four equal annual installments on each of the first four anniversaries of December 12, 2025, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. F2: In addition to the RSUs granted on December 12, 2025, this amount reflects (i) 48,449 RSUs granted pursuant to the Plan that will vest in two equal annual installments on each of December 12, 2026 and December 12, 2027; and (ii) 17,900 RSUs granted pursuant to the Plan that will vest on December 12, 2026, in each case subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. Row 2 · 2025-12-15 · Sale · Disposed 16,850 · Balance 258,795 F3: The transaction reported reflects the disposition of Common Stock to cover taxes due in connection with the vesting of RSUs on December 12, 2025. The RSUs were granted to the Reporting Person on December 12, 2023 and December 12, 2024. F2: In addition to the RSUs granted on December 12, 2025, this amount reflects (i) 48,449 RSUs granted pursuant to the Plan that will vest in two equal annual installments on each of December 12, 2026 and December 12, 2027; and (ii) 17,900 RSUs granted pursuant to the Plan that will vest on December 12, 2026, in each case subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). The RSUs will vest in four equal annual installments on each of the first four anniversaries of December 12, 2025, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.
F2: In addition to the RSUs granted on December 12, 2025, this amount reflects (i) 48,449 RSUs granted pursuant to the Plan that will vest in two equal annual installments on each of December 12, 2026 and December 12, 2027; and (ii) 17,900 RSUs granted pursuant to the Plan that will vest on December 12, 2026, in each case subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.
F3: The transaction reported reflects the disposition of Common Stock to cover taxes due in connection with the vesting of RSUs on December 12, 2025. The RSUs were granted to the Reporting Person on December 12, 2023 and December 12, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2025 Filed Dec 16, 2025 16:12 UTC | DocGo Inc. DCGO · Entity 7359 | SaleCommon Stock | 16,850 | $0.91 | $15,333.50 |
DisclosureSEC source: 0001331867-25-000004 · wk-form4_1765919568.xml · nonDerivative · entry 2 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 258,795 F3 · shares: The transaction reported reflects the disposition of Common Stock to cover taxes due in connection with the vesting of RSUs on December 12, 2025. The RSUs were granted to the Reporting Person on December 12, 2023 and December 12, 2024. F2 · balance_after: In addition to the RSUs granted on December 12, 2025, this amount reflects (i) 48,449 RSUs granted pursuant to the Plan that will vest in two equal annual installments on each of December 12, 2026 and December 12, 2027; and (ii) 17,900 RSUs granted pursuant to the Plan that will vest on December 12, 2026, in each case subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 16:12 UTC | DocGo Inc. DCGO · Entity 7359 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001331867-25-000004 · wk-form4_1765919568.xml · nonDerivative · entry 1 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,645 F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). The RSUs will vest in four equal annual installments on each of the first four anniversaries of December 12, 2025, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. F2 · balance_after: In addition to the RSUs granted on December 12, 2025, this amount reflects (i) 48,449 RSUs granted pursuant to the Plan that will vest in two equal annual installments on each of December 12, 2026 and December 12, 2027; and (ii) 17,900 RSUs granted pursuant to the Plan that will vest on December 12, 2026, in each case subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. Read SEC document |
| December 16, 2024 Filed Dec 16, 2024 17:22 UTC | DocGo Inc. DCGO · Entity 7359 | SaleCommon Stock | 23,088 | $4.44 | $102,510.72 |
DisclosureSEC source: 0001822359-24-000108 · wk-form4_1734387738.xml · nonDerivative · entry 2 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,645 F3 · shares: The transaction reported reflects the disposition of Common Stock to cover taxes due in connection with the vesting of RSUs. The RSUs were granted to the Reporting Person on December 12, 2023. F2 · balance_after: In addition to the RSUs granted on December 12, 2024, this amount reflects 72,674 RSUs granted pursuant to the Plan that will vest in three equal annual installments on each of December 12, 2025, December 12, 2026 and December 12, 2027, in each case subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 17:22 UTC | DocGo Inc. DCGO · Entity 7359 | GrantCommon Stock | 35,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001822359-24-000108 · wk-form4_1734387738.xml · nonDerivative · entry 1 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,733 F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). The RSUs will vest in two equal annual installments on each of the first two anniversaries of December 12, 2024, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. F2 · balance_after: In addition to the RSUs granted on December 12, 2024, this amount reflects 72,674 RSUs granted pursuant to the Plan that will vest in three equal annual installments on each of December 12, 2025, December 12, 2026 and December 12, 2027, in each case subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. Read SEC document |
| May 13, 2024 Filed May 13, 2024 16:34 UTC | DocGo Inc. DCGO · Entity 7359 | PurchaseCommon Stock | 10,000 | $3.13 | $31,300.00 |
DisclosureSEC source: 0001822359-24-000049 · wk-form4_1715632431.xml · nonDerivative · entry 1 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,933 F1 · balance_after: Reflects (i) 96,899 restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") that will vest in four equal annual installments on each of the first four anniversaries of December 12, 2023 and (ii) 32,946 RSUs granted pursuant to the Plan that will vest on December 12, 2024, in each case subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 17:07 UTC | DocGo Inc. DCGO · Entity 7359 | GrantCommon Stock | 32,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001822359-23-000050 · wk-form4_1702591614.xml · nonDerivative · entry 2 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,933 F3 · shares: Represents RSUs granted pursuant to the Plan that will vest on December 12, 2024, subject to the terms of the Plan. F2 · balance_after: Reflects 23,088 RSUs granted pursuant to the Plan that will vest on December 15, 2023, subject to the terms of the Plan. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 17:07 UTC | DocGo Inc. DCGO · Entity 7359 | GrantCommon Stock | 96,899 | $0.00 | $0.00 |
DisclosureSEC source: 0001822359-23-000050 · wk-form4_1702591614.xml · nonDerivative · entry 1 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,987 F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") that will vest in four equal annual installments on each of the first four anniversaries of December 12, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. F2 · balance_after: Reflects 23,088 RSUs granted pursuant to the Plan that will vest on December 15, 2023, subject to the terms of the Plan. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:32 UTC | DocGo Inc. DCGO · Entity 7359 | Exercise / conversionOptions to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001822359-23-000017 · wk-form4_1696455118.xml · derivative · entry 3 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,902 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of options effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023 (the "10b5-1 Plan"). F5 · derivative.exercise_date: The options vested in three equal annual installments beginning on November 12, 2020 and expire January 1, 2030, subject to the terms of the Option Agreement entered into with Ambulnz Inc. and assumed by the Issuer on November 5, 2021. F5 · derivative.expiration_date: The options vested in three equal annual installments beginning on November 12, 2020 and expire January 1, 2030, subject to the terms of the Option Agreement entered into with Ambulnz Inc. and assumed by the Issuer on November 5, 2021. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:32 UTC | DocGo Inc. DCGO · Entity 7359 | SaleCommon Stock | 10,000 | $5.29 | $52,900.00 |
DisclosureSEC source: 0001822359-23-000017 · wk-form4_1696455118.xml · nonDerivative · entry 2 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,088 F3 · kind: Sale of shares effected pursuant to the 10b5-1 Plan. F4 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $5.19 to $5.39. Upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F2 · balance_after: Reflects 23,088 restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"), which will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:32 UTC | DocGo Inc. DCGO · Entity 7359 | Exercise / conversionCommon Stock | 10,000 | $1.59 | $15,900.00 |
DisclosureSEC source: 0001822359-23-000017 · wk-form4_1696455118.xml · nonDerivative · entry 1 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of options effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023 (the "10b5-1 Plan"). F2 · balance_after: Reflects 23,088 restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"), which will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 17:33 UTC | DocGo Inc. DCGO · Entity 7359 | Exercise / conversionOptions to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001822359-23-000014 · wk-form4_1695159177.xml · derivative · entry 3 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,902 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of options effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023 (the "10b5-1 Plan"). F5 · derivative.exercise_date: The options vested in three equal annual installments beginning on November 12, 2020 and expire January 1, 2030, subject to the terms of the Option Agreement entered into with Ambulnz Inc. and assumed by the Issuer on November 5, 2021. F5 · derivative.expiration_date: The options vested in three equal annual installments beginning on November 12, 2020 and expire January 1, 2030, subject to the terms of the Option Agreement entered into with Ambulnz Inc. and assumed by the Issuer on November 5, 2021. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 17:33 UTC | DocGo Inc. DCGO · Entity 7359 | SaleCommon Stock | 10,000 | $5.91 | $59,100.00 |
DisclosureSEC source: 0001822359-23-000014 · wk-form4_1695159177.xml · nonDerivative · entry 2 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,088 F3 · kind: Sale of shares effected pursuant to the 10b5-1 Plan. F4 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $5.61 to $6.24. Upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F2 · balance_after: Reflects 23,088 restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"), which will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 17:33 UTC | DocGo Inc. DCGO · Entity 7359 | Exercise / conversionCommon Stock | 10,000 | $1.59 | $15,900.00 |
DisclosureSEC source: 0001822359-23-000014 · wk-form4_1695159177.xml · nonDerivative · entry 1 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of options effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023 (the "10b5-1 Plan"). F2 · balance_after: Reflects 23,088 restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"), which will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. Read SEC document |
| August 22, 2023 Filed Aug 24, 2023 17:02 UTC | DocGo Inc. DCGO · Entity 7359 | Exercise / conversionOptions to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001822359-23-000006 · wk-form4_1692910911.xml · derivative · entry 3 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,902 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of options effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023 (the "10b5-1 Plan"). F5 · derivative.exercise_date: On January 2, 2020, the Reporting Person was granted options (the "Options") exercisable for an aggregate of 32,902 shares of the Issuer's common stock ("Common Stock") at an aggregate exercise price of $52,173, or $1.59 per share. The Options vested in three equal annual installments beginning on November 12, 2020 and expire January 1, 2030, subject to the terms of the Option Agreement entered into with Ambulnz Inc. and assumed by the Issuer on November 5, 2021. F5 · derivative.expiration_date: On January 2, 2020, the Reporting Person was granted options (the "Options") exercisable for an aggregate of 32,902 shares of the Issuer's common stock ("Common Stock") at an aggregate exercise price of $52,173, or $1.59 per share. The Options vested in three equal annual installments beginning on November 12, 2020 and expire January 1, 2030, subject to the terms of the Option Agreement entered into with Ambulnz Inc. and assumed by the Issuer on November 5, 2021. F5 · balance_after: On January 2, 2020, the Reporting Person was granted options (the "Options") exercisable for an aggregate of 32,902 shares of the Issuer's common stock ("Common Stock") at an aggregate exercise price of $52,173, or $1.59 per share. The Options vested in three equal annual installments beginning on November 12, 2020 and expire January 1, 2030, subject to the terms of the Option Agreement entered into with Ambulnz Inc. and assumed by the Issuer on November 5, 2021. Read SEC document |
| August 22, 2023 Filed Aug 24, 2023 17:02 UTC | DocGo Inc. DCGO · Entity 7359 | SaleCommon Stock | 10,000 | $8.75 | $87,500.00 |
DisclosureSEC source: 0001822359-23-000006 · wk-form4_1692910911.xml · nonDerivative · entry 2 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,088 F3 · kind: Sale of shares effected pursuant to the 10b5-1 Plan. F4 · price: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $8.62 to $9.00. Upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F2 · balance_after: Reflects 23,088 restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"), which will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. Read SEC document |
| August 22, 2023 Filed Aug 24, 2023 17:02 UTC | DocGo Inc. DCGO · Entity 7359 | Exercise / conversionCommon Stock | 10,000 | $1.59 | $15,900.00 |
DisclosureSEC source: 0001822359-23-000006 · wk-form4_1692910911.xml · nonDerivative · entry 1 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of options effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023 (the "10b5-1 Plan"). F2 · balance_after: Reflects 23,088 restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"), which will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 20:02 UTC | DocGo Inc. DCGO · Entity 7359 | GrantCommon Stock | 23,088 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-081111 · ownership.xml · nonDerivative · entry 1 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,088 F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"), which will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. Read SEC document |
| December 07, 2021 Filed Jan 27, 2022 17:20 UTC | DocGo Inc. DCGO · Entity 7359 | GrantOptions to purchase Common Stock · Derivative | 79,208 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004062 · ownership.xml · derivative · entry 1 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,208 Underlying: Common Stock · 79,208 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each cash, subject to the terms of the Plan. Read SEC document |
| December 07, 2021 Filed Jan 27, 2022 16:58 UTC | DocGo Inc. DCGO · Entity 7359 | GrantOptions to purchase Common Stock · Derivative | 79,208 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004021 · ownership.xml · derivative · entry 1 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,208 Underlying: Common Stock · 79,208 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each case, subject to the terms of the Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.